home / stock / azn / azn news


AZN News and Press, AstraZeneca PLC From 05/24/24

Stock Information

Company Name: AstraZeneca PLC
Stock Symbol: AZN
Market: NYSE
Website: astrazeneca.com

Menu

AZN AZN Quote AZN Short AZN News AZN Articles AZN Message Board
Get AZN Alerts

News, Short Squeeze, Breakout and More Instantly...

AZN - Catalyst Watch: Costco earnings, M&A drama, Viking ratings, and a key inflation read

2024-05-24 15:00:53 ET More on the markets S&P 500: It Is All About Liquidity SPY: Time To Be Contrarian And Underweight SPY ETF: Momentum Is In The Cards Stocks have more room to run - Invesco's Kristina Hooper Big bear Mike Wilson changes tune a...

AZN - Overweight Recommendation Issued On AZN By Morgan Stanley

2024-05-24 14:30:04 ET Morgan Stanley analyst issues OVERWEIGHT recommendation for AZN on May 24, 2024 12:54PM ET. The previous analyst recommendation was Overweight. AZN was trading at $78.745 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

AZN - AstraZeneca: Plotting A Bold Path To $80 Billion Revenues, I'm Pausing For Breath

2024-05-24 07:00:00 ET Summary AstraZeneca reported Q1 2024 earnings of $12.7bn, up 19% YoY, and EPS of $2.06, up 13% YoY. The company aims to achieve $80bn in total revenue by 2030, up from $45.8bn in 2023. AZN plans to launch 20 new medicines by 2030, many with the potential...

AZN - Leading The Growth Of Radiopharmaceuticals: Mini Deep Dive On Lantheus

2024-05-23 12:36:52 ET Summary Lantheus Holdings, Inc. excels in radiopharmaceuticals, with PYLARIFY's dominance in PSMA PET imaging. The market for radiopharmaceuticals is expanding beyond all expectations by both industry experts and the company's management. Lantheus is act...

AZN - AstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)

Additional clinical and real-world data from the industry’s largest amyloidosis pipeline will advance understanding of underlying mechanisms of disease and unmet needs AstraZeneca and Alexion, AstraZeneca Rare Disease, will showcase 14 studies, including real-world evidence (RW...

AZN - Nona Biosciences and AstraZeneca sign global license and option agreement

2024-05-23 03:20:19 ET More on AstraZeneca AstraZeneca: A Triple Shot Of Income, Growth, And Value AstraZeneca: Strong In A Weak Market AstraZeneca PLC (AZN) Q1 2024 Earnings Call Transcript AstraZeneca projects $80B in revenue by 2030 AstraZeneca, Am...

AZN - AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024

Back-to-back plenary presentations from LAURA and ADRIATIC Phase III trials reinforce the potential of TAGRISSO ® (osimertinib) and IMFINZI ® (durvalumab) in early lung cancer settings​ DESTINY-Breast06 data underscore potential of ENHERTU ®...

AZN - US Companies Moving the Markets, Morning edition
Tue, May 21, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) fell 55.1% to $0.071 on volume of 238,137,489 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 29.4% to $0.1679 on volume of 103,146,154 shares MGO Global Inc. (MGOL) rose 206.7% to $0.7051 ...

AZN - GSK succeeds in late-stage trials for asthma candidate

2024-05-21 08:32:53 ET More on GSK GSK plc (GSK) Q1 2024 Earnings Call Transcript GSK Trades At Low Price Multiples, But Its Pipeline Needs To Improve GSK plc (GSK) TD Cowen 44th Annual Health Care Conference (Transcript) GSK faces another Zantac whistleblowe...

AZN - AstraZeneca projects $80B in revenue by 2030

2024-05-21 08:00:43 ET More on AstraZeneca AstraZeneca: A Triple Shot Of Income, Growth, And Value AstraZeneca: Strong In A Weak Market AstraZeneca PLC (AZN) Q1 2024 Earnings Call Transcript AstraZeneca, Amgen release mid-stage data on Tezspire for COPD ...

Previous 10 Next 10